AKT1 and esophageal squamous cell carcinoma: By suppressing the expression of these target genes, miR-203a can effectively inhibit the activation of the PI3K/AKT/mTOR signaling pathway, inhibit cell proliferation, thereby affecting the chemical sensitivity of ESCC cells to DDP (Wang L. et al., 2020).